Clinical Trials Browser

Not yet recruiting × zimberelimab × Gastrointestinal × Clear all

NCT06166589 2023-12-12

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Pancreatic Cancer